Biotech

LOS ANGELES, July 25, 2022 (GLOBE NEWSWIRE) — (NASDAQ: ENOB)—Today, Enochian BioSciences (the Company) announced that Dr. Richard (Rich) Whitley, M.D., of the University of Alabama at Birmingham (UAB), will become the Company’s Senior Scientific more...

Evofem Biosciences Unveils New Educational Birth Control Chart to Assist Providers in Patient Contraceptive Counseling PR Newswire SAN DIEGO , July 25, 2022 /PRNewswire/ — Evofem Biosciences, Inc., (Nasdaq: EVFM) today announced it has developed a more...

CNS Pharmaceuticals Urges Shareholders to Vote in Favor of Proxy Proposals for the Upcoming Annual Meeting of Shareholders on July 27, 2022 PR Newswire Company reiterates support of proposals for the authorization to increase number more...

BEDMINSTER, N.J., July 25, 2022 (GLOBE NEWSWIRE) — Matinas BioPharma (NYSE AMER: MTNB), a clinical-stage biopharmaceutical company focused on improving the intracellular delivery of nucleic acids and small molecules with its lipid nanocrystal (LNC) platform technology, more...

EDISON, N.J., July 22, 2022 (GLOBE NEWSWIRE) — Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical mid-stage biopharmaceutical company focused on Artificial Intelligence (“AI”)-driven therapeutic drug development for the treatment of non-alcoholic steatohepatitis (“NASH”) and hepatocellular carcinoma more...

Catalyst Pharmaceuticals CPRX has had a good run this year. The stock has surged 43% in the year-to-date period against the industry ’s decline of 18.7%. Image Source: Zacks Investment Research The upside can be more...

Evofem Biosciences Applauds U.S. House of Representatives for Passing The Right to Contraception Act PR Newswire SAN DIEGO , July 22, 2022 /PRNewswire/ — Evofem Biosciences, Inc., (Nasdaq: EVFM), a women’s healthcare company, today applauded more...

MIAMI, July 22, 2022 (GLOBE NEWSWIRE) — Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress” or the “Company”), an innovative biopharmaceutical company focused on efficiently acquiring, developing and commercializing or monetizing promising therapeutic products and product candidates, more...

Toronto, Ontario–(Newsfile Corp. – July 21, 2022) – On July 8, 2022, Thomas Von Koch (the “Acquiror“), c/o EQT Partners AB, Box 16509, 103 27 Stockholm, Sweden, acquired indirect ownership, through TomEnterprise AB, of an more...

FLORHAM PARK, N.J., July 21, 2022 (GLOBE NEWSWIRE) — Cellectar Biosciences, Inc. (Nasdaq: CLRB), a late-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted treatments for cancer, today announced that, as authorized more...